Cytokinetics (CYTK) is setting up as an interesting event-driven biotech trade into November, with the options market beginning to position around a major FDA decision while the stock sits near the lower end of its recent range.
call spread
Delta Earnings Preview: Options Price a Meaningful Move as Fuel Costs Test the Bull Case
Delta Air Lines (DAL) reports third-quarter earnings before the market opens Friday, October 9, with investors watching whether strong premium travel demand can continue to offset rising fuel costs.
Micron Earnings Preview: Can the AI Memory Boom Keep Delivering?
Micron (MU) reports earnings Wednesday after the close, and this may be one of the most important semiconductor reports of the week.
Erasca’s November Catalyst: Promising Data, High Expectations and Strategic Optionality
The company’s lead drug, ERAS-0015, has shown encouraging early results. On November 20, Erasca will provide updated clinical data that could produce a large move in the stock.